Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

15.05USD
15 Dec 2017
Change (% chg)

$0.21 (+1.42%)
Prev Close
$14.84
Open
$14.87
Day's High
$15.09
Day's Low
$14.76
Volume
347,997
Avg. Vol
154,083
52-wk High
$20.25
52-wk Low
$7.88

Select another date:

Wed, Nov 8 2017

BRIEF-Akebia Therapeutics reports Q3 loss per share $0.49

* Akebia Therapeutics announces third quarter 2017 financial results

BRIEF-Invirsa secures seed financing to develop new approach

* Invirsa secures seed financing to develop new approach to treating common infectious diseases that affect millions annually Source text for Eikon: Further company coverage:

Insider trading suspect out of U.S. jail as judge weighs 'Jekyll & Hyde' risk

BOSTON, Oct 12 A former Akebia Therapeutics Inc employee accused of insider trading was released from jail on Thursday despite a judge's concern that the man's "Dr. Jekyll and Mr. Hyde" tendencies could lead him to violate his bail conditions.

Ex-Akebia employee suspected of insider trading re-arrested

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him "increasingly unhinged" said he would seek the man's detention pending trial.

Ex-Akebia employee suspected of insider trading re-arrested

BOSTON, Sept 22 A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him "increasingly unhinged" said he would seek the man's detention pending trial.

Ex-Akebia employee faces losing bail in insider trading case

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

Ex-Akebia employee faces losing bail in insider trading case

BOSTON, July 20 A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

BRIEF-Muneer Satter reports 6.48 pct stake in Akebia Therapeutics

* Muneer Satter reports 6.48 percent stake in Akebia Therapeutics Inc as of July 5 - SEC filing

BRIEF-Akebia Therapeutics announces proposed public offering of common stock

* Akebia Therapeutics announces proposed public offering of common stock

Select another date: